[[alternative]]The Experience of Adjuvant Hormonal Therapy in Women with Breast Cancer

[[abstract]]本研究經由質性研究方法之深度訪談的方式來了解乳癌婦女服用輔助性荷爾蒙藥物之經驗。以質性分析法之持續性比較分析法進行資料收集及分析。採立意取樣，收案對象為病理診斷為乳癌之婦女，不論過去是否接受過化學藥物治療，目前接受輔助性口服荷爾蒙治療至少六個月以上，願意分享經驗者。 本研究共收案十一位，研究者即為資料收集者，研究工具為個案一般資料、開放式訪談指引，依研究對象決定訪談時間及地點，採面對面的深度訪談並以錄音方式進行資料收集，平均每位訪談時間為六十五分鐘。在研究的嚴謹度方面，依據Lincoln與Guba(1985)對質性研究所提出的信任價值度為考量以作為評鑑標準，包括：準確性、可轉換性、信賴性、可確認性。 研究結果呈現出乳癌婦女服用輔助性荷爾蒙藥物之經驗，共涵蓋三個主題：與藥物共存的經驗特質、服藥的調適及重構生命的意義。希望此研究結果能夠增進臨床上醫療人員對於服用輔助性荷爾蒙治療之過程及經驗的認知，以提供完整的治療與照護[[abstract]]This study was conducted by the method of qualitative analysis of the data collected by in-depth interviews of the women with breast cancer who were taking adjuvant hormonal therapy. The qualitative analysis used constant comparative method for data collection and subsequent data analysis. The target population of this study were women with confirmed pathological diagnosis of breast cancer, regardless of whether she had received chemotherapy in the past; who’s currently receiving adjuvant oral hormonal therapy for at least six months, and was willing to share their experience by participating in this study. This study collected data from a total of 11 cases. The researcher was the data collector. The research tools involved the general information of each case and the open-ended interview guide. Participants decided where and when the interview took place. Data was collected by in-depth face to face interview and the content was recorded by a voice recorder. The average time for each interview was about 65 minutes. For insuring the validity of this study, the method developed by Lincoln and Guba (1985) was used to evaluate and confirm the credibility, transferability, dependability, and confirmability of the study. The results of this study covered three aspects of the experience of the breast cancer patients who received adjuvant hormonal therapy, which includes: the experience of coexistence with the medication, life style adjustment after taking the medication, and restructuring for the meaning of life. Hopefully, this study will raise the cognition of the medical staff for the the experience of adjuvant hormonal therapy in women with breast cancer and provide a comprehensive and holistic patient care